Inauguration emblématique
Shire. Le groupe pharma implanté à Eysins veut réduire l'importance de son débouché américain.
Anne Réthoret
- ABB LTD N45.050%
- ALCON N79.940.48%
- RICHEMONT N144.7-0.07%
- GEBERIT N586.60.14%
- GIVAUDAN N40070.2%
- HOLCIM N94.320.32%
- KUEHNE+NAGEL INT N177.1-3.65%
- LOGITECH N66.761.71%
- LONZA N5842.24%
- NESTLE N87.480.48%
- NOVARTIS N90.63-0.53%
- PARTNERS GROUP N1109.51%
- ROCHE GS256.9-1.15%
- SIKA N206.2-0.05%
- SONOVA HOLDING AG261.23.04%
- SWISS LIFE HOLDING AG N840.60.1%
- SWISS RE N149.50.24%
- SWISSCOM N5430.56%
- UBS GROUP N26.010.93%
- ZURICH INSURANCE N579.4-0.62%
- ABB LTD N45.050%
- ALCON N79.940.48%
- RICHEMONT N144.7-0.07%
- GEBERIT N586.60.14%
- GIVAUDAN N40070.2%
- HOLCIM N94.320.32%
- KUEHNE+NAGEL INT N177.1-3.65%
- LOGITECH N66.761.71%
- LONZA N5842.24%
- NESTLE N87.480.48%
- NOVARTIS N90.63-0.53%
- PARTNERS GROUP N1109.51%
- ROCHE GS256.9-1.15%
- SIKA N206.2-0.05%
- SONOVA HOLDING AG261.23.04%
- SWISS LIFE HOLDING AG N840.60.1%
- SWISS RE N149.50.24%
- SWISSCOM N5430.56%
- UBS GROUP N26.010.93%
- ZURICH INSURANCE N579.4-0.62%